{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:16:27Z","timestamp":1763036187353},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,11,21]],"date-time":"2006-11-21T00:00:00Z","timestamp":1164067200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2006,12,21]]},"DOI":"10.1007\/s00228-006-0224-x","type":"journal-article","created":{"date-parts":[[2006,11,20]],"date-time":"2006-11-20T10:45:03Z","timestamp":1164019503000},"page":"43-50","source":"Crossref","is-referenced-by-count":15,"title":["Modification of CYP2E1 and CYP3A4 activities in haemoglobin E-beta thalassemia patients"],"prefix":"10.1007","volume":"63","author":[{"given":"Nuntiya","family":"Somparn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Upa","family":"Kukongviriyapan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wichittra","family":"Tassaneeyakul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arunee","family":"Jetsrisuparb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veerapol","family":"Kukongviriyapan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,11,21]]},"reference":[{"key":"224_CR1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1365-2710.1998.00135.x","volume":"23","author":"E Tanaka","year":"1998","unstructured":"Tanaka E (1998) Clinical importance of non-genetic and genetic cytochrome P450 function tests in liver disease. J Clin Pharm Ther 23:161\u2013170","journal-title":"J Clin Pharm Ther"},{"key":"224_CR2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1440-1746.1996.tb00007.x","volume":"11","author":"J George","year":"1996","unstructured":"George J, Byth K, Farrell GC (1996) Influence of clinicopathological variables on CYP protein expression in human liver. J Gastroenterol Hepatol 11:33\u201339","journal-title":"J Gastroenterol Hepatol"},{"key":"224_CR3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0741-8329(03)00104-6","volume":"30","author":"AI Cederbaum","year":"2003","unstructured":"Cederbaum AI (2003) Iron and CYP2E1-dependent oxidative stress and toxicity. Alcohol 30:115\u2013120","journal-title":"Alcohol"},{"key":"224_CR4","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/toxsci\/65.2.166","volume":"65","author":"H Jaeschke","year":"2002","unstructured":"Jaeschke H, Gores GJ, Cederbaum AI, Hinson JA, Pessayre D, Lemasters JJ (2002) Mechanisms of hepatotoxicity. Toxicol Sci 65:166\u2013176","journal-title":"Toxicol Sci"},{"key":"224_CR5","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/00043426-200011000-00021","volume":"22","author":"DJ Weatherall","year":"2000","unstructured":"Weatherall DJ (2000) Introduction to the problem of hemoglobin E-beta thalassemia. J Pediatr Hematol Oncol 22:551","journal-title":"J Pediatr Hematol Oncol"},{"key":"224_CR6","first-page":"70","volume":"27","author":"E Shinar","year":"1990","unstructured":"Shinar E, Rachmilewitz EA (1990) Oxidative denaturation of red blood cells in thalassemia. Semin Hematol 27:70\u201382","journal-title":"Semin Hematol"},{"key":"224_CR7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0950-3536(98)80072-3","volume":"11","author":"DJ Weatherall","year":"1998","unstructured":"Weatherall DJ (1998) Pathophysiology of thalassaemia. Baillieres Clin Haematol 11:127\u2013146","journal-title":"Baillieres Clin Haematol"},{"key":"224_CR8","first-page":"1187","volume":"89","author":"C Borgna-Pignatti","year":"2004","unstructured":"Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini MD, Del Vecchio GC, Romeo MA, Forni GL, Gamberini MR, Ghilardi R, Piga A, Cnaan A (2004) Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 89:1187\u20131193","journal-title":"Haematologica"},{"key":"224_CR9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1182\/blood-2003-09-3167","volume":"104","author":"MJ Cunningham","year":"2004","unstructured":"Cunningham MJ, Macklin EA, Neufeld EJ, Cohen AR (2004) Complications of beta-thalassemia major in North America. Blood 104:34\u201339","journal-title":"Blood"},{"key":"224_CR10","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1515\/JPEM.2000.13.6.651","volume":"13","author":"R Gulati","year":"2000","unstructured":"Gulati R, Bhatia V, Agarwal SS (2000) Early onset of endocrine abnormalities in beta-thalassemia major in a developing country. J Pediatr Endocrinol Metab 13:651\u2013656","journal-title":"J Pediatr Endocrinol Metab"},{"key":"224_CR11","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000480970","volume":"12","author":"LL Levitsky","year":"1989","unstructured":"Levitsky LL, Schoeller DA, Lambert GH, Edidin DV (1989) Effect of growth hormone therapy in growth hormone-deficient children on cytochrome P-450-dependent 3-N-demethylation of caffeine as measured by the caffeine 13CO2 breath test. Dev Pharmacol Ther 12:90\u201395","journal-title":"Dev Pharmacol Ther"},{"key":"224_CR12","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00228-004-0806-4","volume":"60","author":"B Sinues","year":"2004","unstructured":"Sinues B, Mayayo E, Fanlo A, Mayayo E Jr, Bernal ML, Bocos P, Bello E, Labarta JI, Ferrandez-Longas A (2004) Effects of growth hormone deficiency and rhGH replacement therapy on the 6beta-hydroxycortisol\/free cortisol ratio, a marker of CYP3A activity, in growth hormone-deficient children. Eur J Clin Pharmacol 60:559\u2013564","journal-title":"Eur J Clin Pharmacol"},{"key":"224_CR13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1042\/bj3090055","volume":"309","author":"T Oinonen","year":"1995","unstructured":"Oinonen T, Lindros KO (1995) Hormonal regulation of the zonated expression of cytochrome P-450 3A in rat liver. Biochem J 309:55\u201361","journal-title":"Biochem J"},{"key":"224_CR14","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00277-004-0934-z","volume":"83","author":"A Aessopos","year":"2004","unstructured":"Aessopos A, Farmakis D, Tsironi M, Deftereos S, Tassiopoulos S, Konstantopoulos K, Rombos J, Papalambros E (2004) Hemodynamic assessment of splenomegaly in beta-thalassemia patients undergoing splenectomy. Ann Hematol 83:775\u2013778","journal-title":"Ann Hematol"},{"key":"224_CR15","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0140-6736(69)91354-3","volume":"1","author":"ES Garnett","year":"1969","unstructured":"Garnett ES, Goddard BA, Markby D, Webber CE (1969) The spleen as an arteriovenous shunt. Lancet 1:386\u2013388","journal-title":"Lancet"},{"key":"224_CR16","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/adc.86.5.344","volume":"86","author":"CK Li","year":"2002","unstructured":"Li CK, Chik KW, Lam CW, To KF, Yu SC, Lee V, Shing MM, Cheung AY, Yuen PM (2002) Liver disease in transfusion dependent thalassaemia major. Arch Dis Child 86:344\u2013347","journal-title":"Arch Dis Child"},{"key":"224_CR17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0378-4347(96)00227-7","volume":"686","author":"RF Frye","year":"1996","unstructured":"Frye RF, Stiff DD (1996) Determination of chlorzoxazone and 6-hydroxychlorzoxazone in human plasma and urine by high-performance liquid chromatography. J Chromatogr B Biomed Appl 686:291\u2013296","journal-title":"J Chromatogr B Biomed Appl"},{"key":"224_CR18","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0731-7085(00)00334-4","volume":"23","author":"M Homma","year":"2000","unstructured":"Homma M, Beckerman K, Hayashi S, Jayewardene AL, Oka K, Gambertoglio JG, Aweeka FT (2000) Liquid chromatographic determination of urinary 6beta-hydroxycortisol to assess cytochrome p-450 3A activity in HIV positive pregnant women. J Pharm Biomed Anal 23:629\u2013635","journal-title":"J Pharm Biomed Anal"},{"key":"224_CR19","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00228-003-0690-3","volume":"59","author":"MM Galteau","year":"2003","unstructured":"Galteau MM, Shamsa F (2003) Urinary 6beta-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals. Eur J Clin Pharmacol 59:713\u2013733","journal-title":"Eur J Clin Pharmacol"},{"key":"224_CR20","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0891-5849(93)90035-S","volume":"15","author":"HH Draper","year":"1993","unstructured":"Draper HH, Squires EJ, Mahmoodi H, Wu J, Agarwal S, Hadley M (1993) A comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials. Free Radic Biol Med 15:353\u2013363","journal-title":"Free Radic Biol Med"},{"key":"224_CR21","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1006\/abio.1995.1079","volume":"224","author":"CP Verdon","year":"1995","unstructured":"Verdon CP, Burton BA, Prior RL (1995) Sample pretreatment with nitrate reductase and glucose-6-phosphate dehydrogenase quantitatively reduces nitrate while avoiding interference by NADP+ when the Griess reaction is used to assay for nitrite. Anal Biochem 224:502\u2013508","journal-title":"Anal Biochem"},{"key":"224_CR22","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0076-6879(94)33041-7","volume":"233","author":"AZ Reznick","year":"1994","unstructured":"Reznick AZ, Packer L (1994) Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 233:357\u2013363","journal-title":"Methods Enzymol"},{"key":"224_CR23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cccn.2004.07.026","volume":"350","author":"D Banerjee","year":"2004","unstructured":"Banerjee D, Jacob J, Kunjamma G, Madhusoodanan UK, Ghosh S (2004) Measurement of urinary hydrogen peroxide by FOX-1 method in conjunction with catalase in diabetes mellitus-a sensitive and specific approach. Clin Chim Acta 350:233\u2013236","journal-title":"Clin Chim Acta"},{"key":"224_CR24","doi-asserted-by":"crossref","first-page":"174","DOI":"10.2337\/diabetes.51.1.174","volume":"51","author":"Q Liang","year":"2002","unstructured":"Liang Q, Carlson EC, Donthi RV, Kralik PM, Shen X, Epstein PN (2002) Overexpression of metallothionein reduces diabetic cardiomyopathy. Diabetes 51:174\u2013181","journal-title":"Diabetes"},{"key":"224_CR25","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/0003-2697(69)90064-5","volume":"27","author":"F Tietze","year":"1969","unstructured":"Tietze F (1969) Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 27:502\u2013522","journal-title":"Anal Biochem"},{"key":"224_CR26","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/j.1552-4604.1998.tb04381.x","volume":"38","author":"RF Frye","year":"1998","unstructured":"Frye RF, Adedoyin A, Mauro K, Matzke GR, Branch RA (1998) Use of chlorzoxazone as an in vivo probe of cytochrome P450 2E1: choice of dose and phenotypic trait measure. J Clin Pharmacol 38:82\u201389","journal-title":"J Clin Pharmacol"},{"key":"224_CR27","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1172\/JCI8814","volume":"105","author":"IA Leclercq","year":"2000","unstructured":"Leclercq IA, Farrell GC, Field J, Bell DR, Gonzalez FJ, Robertson GR (2000) CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J Clin Invest 105:1067\u20131075","journal-title":"J Clin Invest"},{"key":"224_CR28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0009-8981(00)00428-9","volume":"305","author":"D Chakraborty","year":"2001","unstructured":"Chakraborty D, Bhattacharyya M (2001) Antioxidant defense status of red blood cells of patients with beta-thalassemia and Ebeta-thalassemia. Clin Chim Acta 305:123\u2013129","journal-title":"Clin Chim Acta"},{"key":"224_CR29","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cccn.2003.07.010","volume":"338","author":"A Kassab-Chekir","year":"2003","unstructured":"Kassab-Chekir A, Laradi S, Ferchichi S, Haj Khelil A, Feki M, Amri F, Selmi H, Bejaoui M, Miled A (2003) Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia. Clin Chim Acta 338:79\u201386","journal-title":"Clin Chim Acta"},{"key":"224_CR30","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0891-5849(97)00017-8","volume":"23","author":"K Pahan","year":"1997","unstructured":"Pahan K, Smith BT, Singh AK, Singh I (1997) Cytochrome P-450 2E1 in rat liver peroxisomes: downregulation by ischemia\/reperfusion-induced oxidative stress. Free Radic Biol Med 23:963\u2013971","journal-title":"Free Radic Biol Med"},{"key":"224_CR31","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1124\/jpet.102.041582","volume":"304","author":"J Hakkola","year":"2003","unstructured":"Hakkola J, Hu Y, Ingelman-Sundberg M (2003) Mechanisms of down-regulation of CYP2E1 expression by inflammatory cytokines in rat hepatoma cells. J Pharmacol Exp Ther 304:1048\u20131054","journal-title":"J Pharmacol Exp Ther"},{"key":"224_CR32","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0168-8278(96)80214-5","volume":"25","author":"P Stal","year":"1996","unstructured":"Stal P, Johansson I, Ingelman-Sundberg M, Hagen K, Hultcrantz R (1996) Hepatotoxicity induced by iron overload and alcohol. Studies on the role of chelatable iron, cytochrome P450 2E1 and lipid peroxidation. J Hepatol 25:538\u2013546","journal-title":"J Hepatol"},{"key":"224_CR33","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1152\/physrev.1997.77.2.517","volume":"77","author":"CS Lieber","year":"1997","unstructured":"Lieber CS (1997) Cytochrome P-4502E1: its physiological and pathological role. Physiol Rev 77:517\u2013544","journal-title":"Physiol Rev"},{"key":"224_CR34","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1600-0609.2004.00304.x","volume":"73","author":"A Aessopos","year":"2004","unstructured":"Aessopos A, Farmakis D, Hatziliami A, Fragodimitri C, Karabatsos F, Joussef J, Mitilineou E, Diamanti-Kandaraki E, Meletis J, Karagiorga M (2004) Cardiac status in well-treated patients with thalassemia major. Eur J Haematol 73:359\u2013366","journal-title":"Eur J Haematol"},{"key":"224_CR35","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/hep.20673","volume":"41","author":"S Liangpunsakul","year":"2005","unstructured":"Liangpunsakul S, Kolwankar D, Pinto A, Gorski JC, Hall SD, Chalasani N (2005) Activity of CYP2E1 and CYP3A enzymes in adults with moderate alcohol consumption: a comparison with nonalcoholics. Hepatology 41:1144\u20131150","journal-title":"Hepatology"},{"key":"224_CR36","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/hep.1840200212","volume":"20","author":"K Takagi","year":"1994","unstructured":"Takagi K, Ashida H, Utsunomiya J (1994) The effect of splenomegaly on splanchnic hemodynamics in nonalcoholic cirrhosis after distal splenorenal shunt and splenopancreatic disconnection. Hepatology 20:342\u2013348","journal-title":"Hepatology"},{"key":"224_CR37","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1677\/joe.0.1690065","volume":"169","author":"E Charmandari","year":"2001","unstructured":"Charmandari E, Johnston A, Brook CG, Hindmarsh PC (2001) Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Endocrinol 169:65\u201370","journal-title":"J Endocrinol"},{"key":"224_CR38","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00210-003-0815-3","volume":"369","author":"O Burk","year":"2004","unstructured":"Burk O, Wojnowski L (2004) Cytochrome P450 3A and their regulation. Naunyn Schmiedebergs Arch Pharmacol 369:105\u2013124","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"224_CR39","first-page":"63","volume":"1","author":"GP Redmond","year":"1980","unstructured":"Redmond GP, Bell JJ, Nichola PS, Perel JM (1980) Effect of growth hormone on human drug metabolism: time course and substrate specificity. Pediatr Pharmacol (New York) 1:63\u201370","journal-title":"Pediatr Pharmacol (New York)"},{"key":"224_CR40","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1124\/jpet.105.093773","volume":"316","author":"RN Dhir","year":"2006","unstructured":"Dhir RN, Dworakowski W, Thangavel C, Shapiro BH (2006) Sexually dimorphic regulation of hepatic isoforms of human cytochrome p450 by growth hormone. J Pharmacol Exp Ther 316:87\u201394","journal-title":"J Pharmacol Exp Ther"},{"key":"224_CR41","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1365-2125.2003.02049.x","volume":"57","author":"M Wenk","year":"2004","unstructured":"Wenk M, Todesco L, Krahenbuhl S (2004) Effect of St John's wort on the activities of CYP1A2, CYP3A4, CYP2D6, N-acetyltransferase 2, and xantine oxidase in healthy males and females. Br J Clin Pharmacol 57:495\u2013499","journal-title":"Br J Clin Pharmacol"},{"key":"224_CR42","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00008571-199408000-00001","volume":"4","author":"PB Watkins","year":"1994","unstructured":"Watkins PB (1994) Noninvasive tests of CYP3A enzymes. Pharmacogenetics 4:171\u2013184","journal-title":"Pharmacogenetics"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-006-0224-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-006-0224-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-006-0224-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T12:51:35Z","timestamp":1558702295000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-006-0224-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,21]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,12,21]]}},"alternative-id":["224"],"URL":"https:\/\/doi.org\/10.1007\/s00228-006-0224-x","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,21]]}}}